Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 20, 2002

View Archived Issues

Nautilus Biotech designs improved interferon alfa

Nycomed licenses TransMID from KS Biomedix in Europe

Progen licenses preclinical cancer therapy from Unisearch

Evra birth control patch approved in E.U. and Canada

IND submission scheduled for Hynic-Annexin V

Guidant licenses exclusive rights for everolimus in drug-eluting stents

IND filed for rhFXIII in patients with congenital FXIII deficiency

AP-23675 discovered for primary bone cancers and bone metastases

Pilot study for argatroban + tPA in acute ischemic stroke

Anxiolytic-like effects seen for NK1 receptor antagonist NKP-608 in gerbils

New option available for patients with hypertension and diabetic kidney disease

Promising results obtained with BBR-2778 in animal models of MS

Deligoparin does not meet endpoints of pivotal study in ulcerative colitis

Novartis exercises option to license back oral renin inhibitor

Copper chelator exerts antiangiogenic effects via suppression of NF-kB activity

VX-148: a novel IMP dehydrogenase inhibitor with a favorable preclinical profile

Nabi and U. of Maryland researchers identify compounds with broad antiinfective activity

New PDE4 inhibitors designed by Ono

Theravance describes multibinding H1 antagonists for allergic rhinitis and other uses

Novel antiplatelet agents with dual sGC-activating and PDE-inhibitory activity

IPD discloses aldose reductase inhibitors and their use in diabetic complications

Takeda identifies new series of cephem antibiotics

Pfizer returns rights to Onyx products

Broad-spectrum antiviral compounds disclosed in Shire BioChem patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...